Poynard T. Long term prognostic value of the FibroTest in patients with non-alcoholic-fatty-liver disease (NAFLD), compared to chronic hepatitis C (CHC), B (CHB), and alcoholic liver disease (ALD). PS-183.
DNA-pas belooft minder bijwerkingen, betere patiëntenzorg en lagere kosten
apr 2023